Fluorochem Ltd. | UK | Inquire | ||
---|---|---|---|---|
![]() |
+44 (1457) 860-111 | |||
![]() |
enquiries@fluorochem.co.uk | |||
Chemical manufacturer | ||||
International Laboratory Limited | USA | Inquire | ||
---|---|---|---|---|
![]() |
+1 (650) 278-9963 | |||
![]() |
admin@intlab.org | |||
Chemical manufacturer since 2002 | ||||
Matrix Scientific Inc. | USA | Inquire | ||
---|---|---|---|---|
![]() |
+1 (803) 788-9494 | |||
![]() |
sales@matrixscientific.com | |||
Chemical manufacturer | ||||
Ryan Scientific, Inc. | USA | Inquire | ||
---|---|---|---|---|
![]() |
+1 (843)-884-4911 | |||
![]() |
sales@ryansci.com | |||
Chemical manufacturer | ||||
SynQuest Labs, Inc. | USA | Inquire | ||
---|---|---|---|---|
![]() |
+1 (386) 462-0788 | |||
![]() |
info@synquestlabs.com | |||
Chemical manufacturer | ||||
ZereneX Molecular Ltd. | UK | Inquire | ||
---|---|---|---|---|
![]() |
+44 (1204) 527-700 | |||
![]() |
sales@zerenex-molecular.com | |||
Chemical manufacturer | ||||
Zylexa Pharma Ltd. | UK | Inquire | ||
---|---|---|---|---|
![]() |
+44 (845) 299-6009/ | |||
![]() |
sales@zylexa-pharma.com,enquiries@zylexa-pharma.com | |||
Chemical manufacturer | ||||
Name | 4-[(4-Bromophenyl)Sulfonyl]Piperidine Hydrochloride (1:1) |
---|---|
Synonyms | 4-((4-bromophenyl)sulfonyl)piperidine hydrochloride; 4-(4-bromophenylsulfonyl)piperidine hydrochloride; 4-[(4-Bromophenyl)sulfonyl]piperidine |
Molecular Structure | ![]() |
Molecular Formula | C11H15BrClNO2S |
Molecular Weight | 340.66 |
CAS Registry Number | 226400-32-4 |
SMILES | O=S(=O)(c1ccc(Br)cc1)C2CCNCC2.Cl |
InChI | 1S/C11H14BrNO2S.ClH/c12-9-1-3-10(4-2-9)16(14,15)11-5-7-13-8-6-11;/h1-4,11,13H,5-8H2;1H |
InChIKey | YGESRTIVVNWGKU-UHFFFAOYSA-N |
Melting point | 279-283°C (Expl.) |
---|---|
Boiling point | 447.4°C at 760 mmHg (Cal.) |
Flash point | 224.4°C (Cal.) |
Refractive index | (Cal.) |
Safety Description | Irritant |
---|---|
IRRITANT | |
SDS | Available |
Market Analysis Reports |
List of Reports Available for 4-[(4-Bromophenyl)Sulfonyl]Piperidine Hydrochloride (1:1) |